THE DEAL, AT A GLANCE
From the announcementSightera Biosciences
01Who is involvedBacked by 'extreme' patient biology first — TFN sightera biosciencesFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedSightera Biosciences raised Pre-Seed, announced 2026-07-17From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersSightera Biosciences’ $3M pre-seed is a small early-stage capital-flow signal inside an active Healthcare & Life Sciences funding tape, positioning the company within…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Sightera Biosciences · Financing Record
Explore source-linked visual explanations for Sightera Biosciences. Unsupported claims are withheld while source review continues.
Record 8396 · Recorded date: 2026-07-17
Explore company records →